Agilent Q3 Revenues Flat | GenomeWeb

NEW YORK (GenomeWeb) – Agilent Technologies said after the close of the market on Monday that its fiscal third quarter revenues were flat but edged out the consensus Wall Street estimate. 

For the three months ended July 31, the firm posted $1.01 billion in total revenues, the same as the year-ago quarter, but just above the analysts' average estimate of $1 billion. On a core basis, revenues grew 9 percent.  

Orders in Q3 2015 were down about 6 percent year over year to $953 million from $1.02 billion. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.